Publications by authors named "Shuhei Hara"

Claim this Profile
P
Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score.
Yuya Iwamoto, Halle Foss, Yudai Ishiyama, Yuki Taneda, Hirokazu Kagawa, Shuhei Hara

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumab.
Mana Nakata, Fumihiko Urabe, Yu Imai, Kosuke Iwatani, Yuzo Inaba, Shuhei Hara

Int J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study.
Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, Juria Nakano, Kensuke Fujiwara, Shuhei Hara

Jpn J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort study.
Fumihiko Urabe, Hajime Onuma, Kojiro Tashiro, Hidetsugu Takahashi, Naoki Uchida, Shuhei Hara

Transl Androl Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study.
Fumihiko Urabe, Yuki Taneda, Naoki Uchida, Hirokazu Kagawa, Katsuki Muramoto, Shuhei Hara

Jpn J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.
Shuhei Hara, Wataru Fukuokaya, Jun Miki, Rikiya Taoka, Ryoichi Saito, Takashi Kawahara, Kiyoaki Nishihara

Int J Urol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study.
Fumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, Takafumi Yanagisawa, Kota Katsumi, Shuhei Hara

Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study.
Fumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, Hidetsugu Takahashi, Masaki Hashimoto, Shuhei Hara

Prostate Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Shuhei Hara, Fumihiko Urabe, Kojiro Tashiro, Yuma Goto, Yuya Iwamoto

Jpn J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomes.
Shun Saito, Hidetsugu Takahashi, Yuji Yata, Shigeyoshi Takamizawa, Shuhei Hara

Jpn J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.
Fumihiko Urabe, Yu Imai, Yuma Goto, Kojiro Tashiro, Masaki Hashimoto, Kentaro Yoshihara, Shuhei Hara

Jpn J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort study.
Ryotaro Yamaguchi, Hirokazu Kagawa, Kentaro Yoshihara, Shutaro Yamamoto, Shuhei Hara

Transl Androl Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
Shuhei Hara, Keiichiro Mori, Wataru Fukuokaya, Naoya Tomomasa, Takahiro Oguchi, Yushi Suhara

Int J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for overall survival in clinical node-positive patients with upper tract urothelial carcinoma.
Taishiro Sasahara, Takafumi Yanagisawa, Shingo Sugaya, Akira Hisakane, Keigo Sakanaka, Shuhei Hara

Int J Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of timing of urinary drainage on clinical outcomes in patients with obstructive pyelonephritis associated with upper urinary tract stones: a propensity score-matched analysis.
Sotaro Kayano, Takafumi Yanagisawa, Yuji Yata, Keiichiro Miyajima, Shuhei Hara, Taishiro Sasahara

World J Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Takafumi Yanagisawa, Kenichi Hata, Shintaro Narita, Shingo Hatakeyama, Keiichiro Mori, Shuhei Hara

Prostate· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series.
Shuhei Hara, Takaaki Itonaga, Makoto Nishino, Noriyuki Yanagida, Sakura Sato

J Allergy Clin Immunol Glob· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Case of Metastatic Ureteral Cancer Treated with Pembrolizumab without Relapse of Ocular Myasthenia Gravis].
Shuhei Hara, Mariko Honda, Ayaka Kawaharada, Minoru Nakazono, Hajime Onuma

Hinyokika Kiyo· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments of real-time emittance monitors.
Yasuyuki Morita, Mitsuhiro Fukuda, Tetsuhiko Yorita, Hiroki Kanda, Kichiji Hatanaka, Shuhei Hara, Takafumi Hara

Rev Sci Instrum· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cesarean section in the setting of severe pulmonary hypertension requiring extracorporeal life support.
Ryosuke Hara, Shuhei Hara, Chin Siang Ong, Gary Schwartz, Christopher Sciortino

Gen Thorac Cardiovasc Surg· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Polarized Surface-Enhanced Infrared Spectroscopy by Fano-Resonant Asymmetric Metamaterials.
Atsushi Ishikawa, Shuhei Hara, Takuo Tanaka, Yasuhiko Hayashi, Kenji Tsuruta

Sci Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regiospecific [2 + 2] photocyclodimerization of trans-4-styrylpyridines templated by cucurbit[8]uril.
Asao Nakamura, Hiromi Irie, Shuhei Hara, Mai Sugawara, Shinji Yamada

Photochem Photobiol Sci· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis